[Histonet] Hep Par 1 validation

[Cartun, Richard]

FYI - be careful; other cancers besides HCC can show immunoreactivity for Hepatocyte antigen (clone OCH1E5).  Arginase (rabbit mAb) is another marker that can be used for HCC and it is more specific than Hepatocyte antigen.

Richard

Richard W. Cartun, MS, PhD
Director, Histology & Immunopathology
Director, Biospecimen Collection Programs
Assistant Director, Anatomic Pathology
Hartford Hospital
80 Seymour Street
Hartford, CT  06102
(860) 545-1596 Office
(860) 545-2204 Fax
richard.cartun <@t> hhchealth.org

________________________________________
From: histonet-bounces <@t> lists.utsouthwestern.edu [histonet-bounces <@t> lists.utsouthwestern.edu] on behalf of Cynthia Robinson [robinsoc <@t> mercyhealth.com]
Sent: Friday, October 04, 2013 1:09 PM
To: histonet
Subject: [Histonet] Hep Par 1 validation

I am wondering if anyone has hepatoblastoma....either in liver or metastatic tumor....in their tissue bank. I am working up Hep Par 1 and have a few cases but would like a few more. We are working up this antibody to use in metastatic case with unknown primary as a way to rule out possibilities. My pathologist would really like to see a case with tumor surrounded by normal liver, if possible. If you can help please contact me. I have control blocks I would be willing to trade.

Thanks.....Cindi

Cindi Robinson HT(ASCP)
Mercy Medical Center
Dunes Medical Laboratories
350 W Anchor Dr
Dakota Dunes SD 57049
phone-712-279-2768
robinsoc <@t> mercyhealth.com



_______________________________________________
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message, including any attachments.